Charlotte's Web Holdings, Inc. (6CW.F)
- Previous Close
0.0535 - Open
0.0565 - Bid 0.0565 x --
- Ask 0.0955 x --
- Day's Range
0.0565 - 0.0565 - 52 Week Range
0.0355 - 0.1740 - Volume
2,200 - Avg. Volume
128 - Market Cap (intraday)
12.21M - Beta (5Y Monthly) 2.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1700 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products. Its product categories include full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushrooms; and pet products under the Charlotte's Web, CBD CLINIC, and CBD MEDIC brand names. The company's products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds. It distributes its products through retail outlets, health care practitioners, and distributors, as well as online through its website and other third-party e-commerce sites. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Louisville, Colorado.
www.charlottesweb.com112
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 6CW.F
View MorePerformance Overview: 6CW.F
Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6CW.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6CW.F
View MoreValuation Measures
Market Cap
12.06M
Enterprise Value
44.49M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.19
Price/Book (mrq)
0.35
Enterprise Value/Revenue
1.01
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-60.09%
Return on Assets (ttm)
-15.03%
Return on Equity (ttm)
-72.23%
Revenue (ttm)
49.67M
Net Income Avi to Common (ttm)
-29.85M
Diluted EPS (ttm)
-0.1700
Balance Sheet and Cash Flow
Total Cash (mrq)
24.02M
Total Debt/Equity (mrq)
219.06%
Levered Free Cash Flow (ttm)
-13.64M